Global Information
회사소개 | 문의 | 비교리스트

세계의 겸상 적혈구 빈혈 검사 및 스크리닝 시장 : 기술별, 연령층별, 부문별 시장 규모, 점유율, 동향 분석과 예측(2020-2027년)

Sickle Cell Anemia Testing & Screening Market Size, Share & Trends Analysis Report By Technology (Hemoglobin Electrophoresis, POC, HPLC), By Age Group, By Sector Type, And Segment Forecasts, 2020 - 2027

리서치사 Grand View Research, Inc.
발행일 2020년 06월 상품 코드 948094
페이지 정보 영문 150 Pages
가격
US $ 5,950 ₩ 7,013,000 Unprintable PDF (Single User License)
US $ 6,950 ₩ 8,192,000 Printable PDF (5-User License)
US $ 8,950 ₩ 10,550,000 Printable PDF (Enterprise License)


세계의 겸상 적혈구 빈혈 검사 및 스크리닝 시장 : 기술별, 연령층별, 부문별 시장 규모, 점유율, 동향 분석과 예측(2020-2027년) Sickle Cell Anemia Testing & Screening Market Size, Share & Trends Analysis Report By Technology (Hemoglobin Electrophoresis, POC, HPLC), By Age Group, By Sector Type, And Segment Forecasts, 2020 - 2027
발행일 : 2020년 06월 페이지 정보 : 영문 150 Pages

세계의 겸상 적혈구 빈혈 검사 및 스크리닝 시장은 2020-2027년 5.44%의 CAGR로 계속 확대되며, 2027년에는 3억 4,071만 달러에 달할 전망입니다. 겸상 적혈구 헤모글로빈 변이체에는 HbS, HbA, HbC가 있으며, 이 변이체를 명확하게 구별하기 위해 다양한 검사법이 개발되고 있습니다. 겸상 적혈구증은 HbS가 원인인자인 유전성 질환이며, 개발도상국을 중심으로 세계 각국에서 볼 수 있습니다. 현재 환자의 혈액 도말 표본에 포함되는 겸상 적혈구를 스마트폰의 현미경으로 자동 스크리닝하도록 설계된 딥러닝 프레임워크의 개발이 진행되고 있으며, 향후 시장에 새로운 길이 열릴 가능성이 있습니다.

세계의 겸상 적혈구 빈혈 검사 및 스크리닝 시장을 조사했으며, 시장 동향, 업계의 전망, 기술별, 연령층별, 부문별, 지역별 분석, 경쟁 구도 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 방법과 범위

제2장 시장의 정의

제3장 개요

제4장 시장 변동 요인, 동향, 전망

  • 시장 구분
  • 겸상 적혈구 빈혈(HbS) 검사 및 스크리닝
  • 보급과 성장 전망
  • 업계에 대한 코로나바이러스 감염증(COVID-19)의 영향

제5장 업계 전망

  • 시장 성장 촉진요인 분석
    • 겸상 적혈구증의 부담을 최소한으로 억제하는 전략
    • 세계의 겸상 적혈구증 유병률 상승
  • 시장 성장 저해요인 분석
    • 겸상 적혈구증의 스크리닝과 진단에 관련된 인프라의 과제
  • 시장 기회 분석
    • 겸상 적혈구증의 자동 스크리닝

제6장 사업 환경 분석

  • SWOT 분석
  • Porter의 산업 분석

제7장 경쟁 분석

  • 주요 기업의 시장 영향 분석
  • 시장 진출 전략

제8장 기술별 분석

  • 기술별 동향 분석
  • 헤모글로빈 전기영동
  • 고속 액체 크로마토그래피(HPLC)
  • POC(Point of Care) 검사
  • 기타

제9장 연령층별 분석

  • 연령층별 동향 분석
  • 신생아 스크리닝(12개월 이하)
  • 성인 스크리닝(25세-60세)
  • 기타 연령 그룹(1세-25세, 60세 이상)

제10장 부문별 분석

  • 부문별 동향 분석
  • 정부 연구기관
  • 민간 연구기관
  • 기업 연구소
  • PPP(민관 제휴)

제11장 지역별 분석

  • 지역별 동향 분석
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동과 아프리카

제12장 기업 개요

KSA 20.07.28

List of Tables

  • Table 1 Comparative analysis of commercial tests available for screening sickle cell anemia population
  • Table 2 Top 10 laboratories offering sickle cell anemia screening tests, India
  • Table 3 List of secondary sources
  • Table 4 Prioritization of recommendations for newborn/neonatal screening
  • Table 5 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 6 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 7 North America. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 8 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 9 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 10 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 11 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 12 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 13 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 14 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 15 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 16 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 17 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 18 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 19 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 20 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 21 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 22 Europe. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 23 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 24 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 25 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 26 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 27 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 28 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 29 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 30 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 31 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 32 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 33 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 34 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 35 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 36 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 37 Asia Pacific. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 38 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 39 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 40 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 41 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 42 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 43 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 44 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 45 China sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 46 China sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 47 China sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 48 China sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 49 China sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 50 India sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 51 India sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 52 India sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 53 India sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 54 India sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 55 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 56 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 57 Latin America. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 58 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 59 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 60 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 61 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 62 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 63 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 64 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 65 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 66 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 67 MEA. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 68 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 69 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
  • Table 70 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
  • Table 71 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
  • Table 72 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
  • Table 73 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
  • Table 74 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million 

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Sickle cell anemia (HbS) testing & screening market: Primary research analysis
  • Fig. 5 Sickle cell anemia testing & screening segment revenue modeling
  • Fig. 6 Sickle cell anemia testing & screening market revenue modeling
  • Fig. 7 Sickle cell anemia testing & screening market age group revenue modeling
  • Fig. 8 Sickle cell anemia testing & screening newborn screening algorithm
  • Fig. 9 Sample load analysis across laboratories, tier - wise
  • Fig. 10 Sickle cell anemia testing & screening market regional revenue modeling
  • Fig. 11 Sickle cell anemia testing & screening market regional revenue modeling
  • Fig. 12 Market research approaches
  • Fig. 13 Value-chain based sizing & forecasting
  • Fig. 14 QFD modeling for market share assessment
  • Fig. 15 Market formulation & validation
  • Fig. 16 Sickle cell anemia (HbS) testing & screening market snapshot
  • Fig. 17 Sickle cell anemia (HbS) testing & screening market segmentation
  • Fig. 18 Sickle cell anemia (HbS) testing & screening, parent market outlook
  • Fig. 19 Penetration and growth prospect mapping
  • Fig. 20 Sickle cell anemia (HbS) testing & screening market driver impact
  • Fig. 21 Strategies to minimize the sickle cell disease burden
  • Fig. 22 Prevalence of sickle - cell anemia across the globe & India, 2016 - 2019
  • Fig. 23 Babies with sickle - cell anemia across the globe & India, 2016 - 2019
  • Fig. 24 Prevalence rate of sickle - cell anemia across the globe & India, 2016 - 2019 (%)
  • Fig. 25 Sickle cell anemia (HbS) testing & screening market restraint impact
  • Fig. 26 Sickle cell anemia (HbS) testing & screening market opportunity impact
  • Fig. 27 Sickle cell anemia (HbS) testing & screening market SWOT analysis
  • Fig. 28 Sickle cell anemia (HbS) testing & screening market Porter's five forces analysis
  • Fig. 29 Ansoff Matrix
  • Fig. 30 Competition Categorization
  • Fig. 31 Factors impacting market entry strategies
  • Fig. 32 Sickle Cell Anemia (HbS) Testing & Screening market: Technology outlook and key takeaways
  • Fig. 33 Sickle Cell Anemia (HbS) Testing & Screening market: Technology movement analysis
  • Fig. 34 Hb electrophoresis - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 35 Hb electrophoresis - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
  • Fig. 36 Isoelectric focusing based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 37 Isoelectric focusing based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
  • Fig. 38 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 39 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
  • Fig. 40 HPLC - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 41 HPLC - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
  • Fig. 42 POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 43 POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
  • Fig. 44 Lateral flow POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 45 Lateral flow POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
  • Fig. 46 Paper based POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 47 Paper base POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
  • Fig. 48 Other POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 49 Other POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
  • Fig. 50 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 51 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
  • Fig. 52 Sickle cell anemia (HbS) testing & screening market: Age group outlook and key takeaways
  • Fig. 53 Sickle cell anemia (HbS) testing & screening market: Age group movement analysis
  • Fig. 54 Sickle cell anemia (HbS) newborn testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 55 Sickle cell anemia (HbS) adult testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 56 Sickle cell anemia (HbS) testing & screening market for other age groups estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 57 Sickle cell anemia (HbS) testing & screening market: Sector type outlook and key takeaways
  • Fig. 58 Sickle cell anemia (HbS) testing & screening market: Sector type movement analysis
  • Fig. 59 Sickle cell disease government initiatives: U.S.
  • Fig. 60 Sickle cell anemia (HbS) testing & screening market for government labs estimates and forecast, 2016 - 2027
  • Fig. 61 Sickle cell anemia (HbS) testing & screening market for private labs estimates and forecast, 2016 - 2027
  • Fig. 62 Sickle cell anemia (HbS) testing & screening market for corporate labs estimates and forecast, 2016 - 2027
  • Fig. 63 Sickle cell anemia (HbS) testing & screening market for PPP (public - private - partnerships) estimates and forecast, 2016 - 2027
  • Fig64 Sickle cell anemia (HbS) testing & screening market: Regional outlook and key takeaways
  • Fig. 65 Sickle cell anemia (HbS) testing & screening market: Regional movement analysis
  • Fig. 66 North America sickle cell anemia (HbS) testing & screening market overview
  • Fig. 67 North America sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 68 U.S.
  • Fig. 69 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 70 Canada sickle cell anemia (HbS) testing & screening market overview
  • Fig. 71 Canada sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 72 Europe Sickle Cell Anemia (HbS) Testing & Screening market overview
  • Fig. 73 Europe sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig 74 Germany sickle cell anemia (HbS) testing & screening market overview
  • Fig. 75 Germany Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 76 U.K. sickle cell anemia (HbS) testing & screening market overview
  • Fig. 77 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 78 Asia Pacific Sickle Cell Anemia (HbS) Testing & Screening market overview
  • Fig. 79 Asia Pacific Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 80 Japan sickle cell anemia (HbS) testing & screening market overview
  • Fig. 81 Japan Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 82 China sickle cell anemia (HbS) testing & screening market overview
  • Fig. 83 China Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 84 India Sickle Cell Anemia (HbS) Testing & Screening market overview
  • Fig. 85 India Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 86 Latin America sickle cell anemia (HbS) testing & screening market overview
  • Fig. 87 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 88 Brazil Sickle Cell Anemia (HbS) Testing & Screening market overview
  • Fig. 89 Brazil Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 90 Middle East & Africa Sickle Cell Anemia (HbS) Testing & Screening market overview
  • Fig. 91 MEA sickle cell anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 92 South Africa sickle cell anemia (HbS) testing & screening market overview
  • Fig. 93 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)

Sickle Cell Anemia Testing & Screening Market Growth & Trends

The global sickle cell anemia testing and screening market size is expected to reach USD 340.71 million by 2027, expanding at a CAGR of 5.44% from 2020 to 2027, according to a new report by Grand View Research, Inc. Hemoglobin S (HbS) is the causative factor for sickle cell disease and is currently the most prevailing disease or genetic abnormality across the globe, specifically across developing economies.

Sickle cell hemoglobin variants are inclusive of HbS, HbA, and HbC. Different tests have been developed to perform a clear distinction between all the three above-mentioned hemoglobin variants. Development of a deep learning framework designed to perform automated screening of sickle cell anemia in blood smear sample of patients via a smartphone microscope is set to open up new avenues for the market in the near future.

The market is moderately consolidated, wherein the key industry participants are striving to sustain market competition via partnerships, acquisitions, and expanding their business across newborn testing market space. Whereas, emerging companies are exploring potential of point-of-care tests to gain a competitive edge in the market.

A steep increase in the uptake of Hb electrophoresis and HPLC across government-initiated newborn screening programs and assessment studies have resulted in robust market penetration. This has, in turn, caught the attention of companies who are keen on modifying their existing product line, further amplifying consumption of the same.

Sickle Aell Anemia Testing & Screening Market Report Highlights

  • By age group, several newborn screening programs have been employed across the globe to effectively manage the burden of this disease. These programs make use of different tests such as isoelectric focusing/ cellulose acetate electrophoresis, high-performance liquid chromatography (HPLC), and solubility tests
  • Based on technology, POC lateral flow assays are the most preferred testing methodologies in screening programs, forming the conventional means of testing
  • On the basis of sector type, government laboratories have witnessed maximum employment of sickle cell tests over the years
  • Government laboratories have actively participated in promoting the adoption of these tests by encouraging population-based sickle cell testing
  • Rise in the demand for federal and foundation funding to address healthcare disparities treatments and diagnosis of diseases, such as hemoglobinopathies and cystic fibrosis, is expected to drive the attention of the regulatory agencies.

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 GVR's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Sickle Cell Anemia Testing & Screening Market: Segment Revenue And Growth Analysis
    • 1.5.2 Sickle Cell Anemia Testing & Screening Market: Technology Revenue And Growth Analysis
    • 1.5.3 Sickle Cell Anemia Testing & Screening Market: Age Group Revenue And Growth Analysis
    • 1.5.4 Sickle Cell Anemia Testing & Screening Market: Sector Revenue And Growth Analysis
    • 1.5.5 Sickle Cell Anemia Testing & Screening Market: Regional Revenue And Growth Analysis
    • 1.5.6 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1 Approach 1: Commodity Flow Approach
      • 1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
  • 1.8 Global Market: Cagr Calculation
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Summary

Chapter 4 Market Variables, Trends & Scope

  • 4.1 Market Segmentation
  • 4.2 Sickle Cell Anemia (Hbs) Testing & Screening Market Lineage Outlook
    • 4.2.1 Parent Market Outlook
  • 4.3 Penetration And Growth Prospect Mapping
  • 4.4 Coronavirus Impact On The Sickle Cell Disease Industry

Chapter 5 Industry Outlook

  • 5.1 Market Drivers Analysis
    • 5.1.1 Increasing Implementation Of Strategies To Minimize The Sickle Cell Disease Burden
      • 5.1.1.1 Newborn/Neonatal Screening
      • 5.1.1.2 Point-Of-Care (Poc) Tests
      • 5.1.1.3 Prioritization Of Newborn/Neonatal Screening To Reduce Sca Burden
    • 5.1.2 Rising Prevalence Of Sickle Cell Disease Across The Globe
  • 5.2 Market Restraint Analysis
    • 5.2.1 Infrastructal Challenges Associated With Screening And Diagnosis Of Sickle Cell Disease
  • 5.3 Market Opportunity Analysis
    • 5.3.1 Automated Screening Of Sickle Cell Disease

Chapter 6 Business Environment Analysis

  • 6.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
  • 6.2 Porter's Five Forces Analysis

Chapter 7 Competitive Analysis

  • 7.1 Market Impact Analysis By Key Participants
    • 7.1.1 Ansoff Matrix
    • 7.1.2 Company/Competition Categorization (Primary & Secondary Market Participants)
  • 7.2 Market Entry Strategies
    • 7.2.1 Cost Analysis Point-Of-Care Tests: Sickle Cell Disease Screening

Chapter 8 Technology Business Analysis

  • 8.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Technology Movement Analysis
  • 8.2 Hemoglobin Electrophoresis
    • 8.2.1 Hb Electrophoresis-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 8.2.2 Hb Electrophoresis-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
    • 8.2.3 Isoelectric Focussing
      • 8.2.3.1 Isoelectric Focussing-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
      • 8.2.3.2 Isoelectric Focussing-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
    • 8.2.4 Other Electrophoresis-Based
      • 8.2.4.1 Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
      • 8.2.4.2 Other Electrophoresis-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
  • 8.3 High-Performance Liquid Chromatography (Hplc)
    • 8.3.1 Hplc-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 8.3.2 Hplc-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
  • 8.4 Point-Of-Care Tests
    • 8.4.1 Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 8.4.2 Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
    • 8.4.3 Lateral Flow Immunoassay Poc
      • 8.4.3.1 Lateral Flow Immunoassay Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
      • 8.4.3.2 Lateral Flow Immunoassay Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
    • 8.4.4 Paper Based Poc
      • 8.4.4.1 Paper Based Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
      • 8.4.4.2 Paper Based Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
    • 8.4.5 Other Poc
      • 8.4.5.1 Other Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
      • 8.4.5.2 Other Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
  • 8.5 Other Tests
    • 8.5.1 Other Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
    • 8.5.2 Other Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)

Chapter 9 Age Group Business Analysis

  • 9.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Age Group Movement Analysis
  • 9.2 Newborn Screening (12 Months And Below)
    • 9.2.1 Sickle Cell Anemia (Hbs) Newborn Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
  • 9.3 Adult Screening (25 To 60 Years)
    • 9.3.1 Sickle Cell Anemia (Hbs) Adult Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
  • 9.4 Other Age Groups (1 To 25 & Above 60 Years)
    • 9.4.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Other Age Groups Estimates And Forecast, 2016 - 2027 (USD Million)

Chapter 10 Sector Type Business Analysis

  • 10.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Sector Type Movement Analysis
  • 10.2 Government Labs
    • 10.2.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Government Labs Estimates And Forecast, 2016-2027
  • 10.3 Private Labs
    • 10.3.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Private Labs Estimates And Forecast, 2016-2027
  • 10.4 Corporate Labs
    • 10.4.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Corporate Labs Estimates And Forecast, 2016-2027
  • 10.5 Ppp (Public-Private-Partnerships)
    • 10.5.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Ppp (Public-Private-Partnerships) Estimates And Forecast, 2016-2027

Chapter 11 Regional Business Analysis

  • 11.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Regional Movement Analysis
  • 11.2 North America
    • 11.2.1 North America Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
    • 11.2.2 U.S.
      • 11.2.2.1 U.S. Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
    • 11.2.3 Canada
      • 11.2.3.1 Canada Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
  • 11.3 Europe
    • 11.3.1 Europe Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
    • 11.3.2 Germany
      • 11.3.2.1 Germany Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
    • 11.3.3 U.K.
      • 11.3.3.1 U.K. Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
  • 11.4 Asia-Pacific
    • 11.4.1 Asia Pacific Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
    • 11.4.2 Japan
      • 11.4.2.1 Japan Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
    • 11.4.3 China
      • 11.4.3.1 China Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
    • 11.4.4 India
      • 11.4.4.1 India Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
  • 11.5 Latin America
    • 11.5.1 Latin America Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
    • 11.5.2 Brazil
      • 11.5.2.1 Brazil Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
  • 11.6 Middle East And Africa
    • 11.6.1 Mea Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
    • 11.6.2 South Africa
      • 11.6.2.1 South Africa Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)

Chapter 12 Company Profiles

  • 12.1 Company Profiles
    • 12.1.1. STRECK
      • 12.1.1.1 Company overview
      • 12.1.1.2 Financial performance
      • 12.1.1.3 Product benchmarking
      • 12.1.1.4 Strategic Initiatives
    • 12.1.2 BIOMEDOMICS INC.
      • 12.1.2.1 Company overview
      • 12.1.2.2 Product benchmarking
      • 12.1.2.3 Strategic initiatives
    • 12.1.3 Hemex Health
      • 12.1.3.1 Company overview
      • 12.1.3.2 Product benchmarking
      • 12.1.3.3 Strategic initiatives
    • 12.1.4 Silver Lake Research Corporation
      • 12.1.4.1 Company overview
      • 12.1.4.2 Product benchmarking
    • 12.1.5 Request A Test
      • 12.1.5.1 Company overview
      • 12.1.5.2 Product benchmarking
    • 12.1.6 Laboratory Corporation of America Holdings
      • 12.1.6.1 Company overview
      • 12.1.6.2 Financial performance
      • 12.1.6.3 Product benchmarking
    • 12.1.7 Quest Diagnostics Incorporated
      • 12.1.7.1 Company overview
      • 12.1.7.2 Financial performance
      • 12.1.7.3 Product benchmarking
      • 12.1.7.4 Strategic Initiatives
    • 12.1.8 HALCYON BIOMEDICAL INCORPORATED
      • 12.1.8.1 Company overview
      • 12.1.8.2 Product benchmarking
      • 12.1.8.3 Strategic Initiatives
    • 12.1.9 PerkinElmer Inc.
      • 12.1.9.1 Company overview
      • 12.1.9.2 Financial performance
      • 12.1.9.3 Product benchmarking
    • 12.1.10 Bio-Rad Laboratories, Inc.
      • 12.1.10.1 Company overview
      • 12.1.10.2 Financial performance
      • 12.1.10.3 Product benchmarking
    • 12.1.11 Daktari Diagnostics .
      • 12.1.11.1 Company overview
      • 12.1.11.2 Financial performance
      • 12.1.11.3 Product benchmarking
      • 12.1.11.4 Strategic Initiatives
Back to Top
전화 문의
F A Q